|
Baseline
|
|
6 months (May–Nov 2015)
|
128
|
126
|
11.7; 7.7–16.1
|
10.2; 6.4–32.8
|
0.130
|
|
12 months (May 2015–April 2016)
|
150
|
146
|
13.7; 9.8–19.6
|
11.9; 7.5–36.8
|
0.105
|
|
Post-MDA
|
|
3 months (May–Aug 2016)
|
31
|
41
|
2.8; 0.0–10.3
|
3.3; 0.9–8.0
|
0.721
|
|
6 months (May–Nov 2016)1
|
43
|
52
|
3.9; 0.0–13.1
|
4.2; 2.1–8.0
|
0.442
|
|
12 months (May 2016–April 2017)
|
58
|
71
|
5.3; 0.0–13.1
|
5.8; 3.1–10.4
|
0.382
|
|
16 months (May 2016–Aug 2017)
|
143
|
208
|
13.1; 5.4–28.0
|
16.9; 6.7–31.8
|
0.130
|
|
Post-MDA cases without travel history
|
|
3 months (May–Aug 2016)
|
18
|
23
|
1.6; 0.0–9.3
|
1.9; 0.0–8.0
|
0.716
|
|
6 months (May–Nov 2016)
|
22
|
29
|
2.0; 0.0–11.2
|
2.4; 0.9–8.0
|
0.277
|
|
12 months (May 2016–April 2017)
|
31
|
41
|
2.8; 0.0–11.2
|
3.3; 1.1–8.0
|
0.315
|
|
16 months (May 2016–Aug 2017)
|
109
|
160
|
10.0; 5.4–26.1
|
13.0; 2.7–30.8
|
0.279
|
